论文信息 - Updated Organ Response Results of an Open-Label Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis Receiving Anti-Plasma Cell Therapy - 字舞流文

Updated Organ Response Results of an Open-Label Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis Receiving Anti-Plasma Cell Therapy

M. Liedtke | J. Zonder | H. Staley | M. Kurman | M. Harnett | S. Sobolov | C. Samaras | F. Anwer | J. Valent | Sherry Fada | J. Jobes | J. Khouri | M. Spector | E. Daniel | Kristen Schlueter | J. Silowsky | Kathleen Stefunek